143 Mesothelin (MSLN) targeting allogeneic CAR T cells engineered to overcome tumor immunosuppressive microenvironment | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Regular and Young Investigator Award Abstracts

Cellular Therapies

143 Mesothelin (MSLN) targeting allogeneic CAR T cells engineered to overcome tumor immunosuppressive microenvironment

Free

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

	Abstract	Full	Pdf
Nov 2021	716	0	66
Dec 2021	134	0	22
Jan 2022	88	0	14
Feb 2022	110	0	17
Mar 2022	330	0	12
Apr 2022	96	0	9
May 2022	54	0	19
Jun 2022	48	0	12
Jul 2022	26	0	4
Aug 2022	67	0	7
Sep 2022	34	0	10
Oct 2022	32	0	7
Nov 2022	34	0	15
Dec 2022	20	0	4
Jan 2023	34	0	9
Feb 2023	20	0	3
Mar 2023	16	0	3
Apr 2023	26	0	8
May 2023	48	0	10
Jun 2023	6	0	2
Jul 2023	18	0	19
Aug 2023	9	0	4
Sep 2023	40	0	9
Oct 2023	22	0	2
Nov 2023	28	0	4
Dec 2023	50	0	7
Jan 2024	16	0	1
Feb 2024	18	0	5
Mar 2024	32	0	13
Total	2172	0	317